Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07310082 · ClinicalTrials.gov registry record · NA
Allograft vs. Autograft Nonunion
A NA study, sponsored by Wake Forest University Health Sciences.
- Not yet
- Registry status
- NA
- Development phase
- 156
- Enrollment target
NCT07310082: Clinical Trial NA study, sponsored by Wake Forest University Health Sciences.
NCT07310082 is a NA study that has not yet begun recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 156 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07310082, a NA study, has not yet begun recruiting, sponsored by Wake Forest University Health Sciences.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out if patients treated for nonunion fracture with autograft or allograft return to activity faster.
Primary Outcome
Time to return to work/duty will be measured using the the International Physical Activity Questionnaire (IPAQ).The IPAQ is a validated, self-report measure that captures detailed information about participation in a wide range of physical activities, including the number of days and amount of time spent in the previous 7 days. Responses for each type of physical activity are then transformed into the number of Metabolic Equivalent for Tasks (METs), and a METs/week is calculated for each patient
Interventions
- PROCEDURE Autograft
- PROCEDURE Allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2026-07 |
| Est. Completion | 2030-12 |
| Phase | NA |
What is known before NCT07310082 opens enrollment
NCT07310082 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Autograft is the first listed.
NCT07310082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07310082 about?
NCT07310082 is a clinical study titled "Allograft vs. Autograft Nonunion". The purpose of this research study is to find out if patients treated for nonunion fracture with autograft or allograft return to activity faster.
What is the current status of trial NCT07310082?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 156 participants. The study started on 2026-07. Estimated completion is 2030-12.
What interventions are being tested in trial NCT07310082?
The interventions under investigation include: Autograft (PROCEDURE), Allograft (PROCEDURE).
Who is sponsoring clinical trial NCT07310082?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07310082's enrollment target sits among peer trials
156 656th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia